StimLabs
The purpose of this observational case series is to assess the use of Corplex P as a resorbable particulate device used to cover, protect, and provide a moist wound environment when added to the standard of care treatment of hard-to-heal wounds.
This is a retrospective, single-center observational case series to assess real-world outcomes of StimLabs dehydrated human umbilical cord particulate used in the management of hard-to-heal wounds, including acute and chronic ulcers. This case series will include real-world data from up to 10 subjects at one participating site. The Corplex P product has been utilized in a variety of patients attending wound clinics for management of partial and full-thickness wounds, pressure ulcers, venous leg ulcers (VLU), diabetic foot ulcers (DFUs), chronic vascular ulcers, and surgical wounds. The device…
Inclusion Criteria: * All consecutive subjects that received a Corplex P device application during wound management in the following retrospective cohort between February 2024 and November 2025. Exclusion Criteria: * Subjects not receiving an initial Corplex P application during treatment
Corplex P is derived from human birth tissue and used in wound management to cover, protect, and provide a moist wound environment.
Arctuva estimate
Actual pay is set by the research site.
Verify or correct the compensation shown for this listing.